Clinical trials
Terminated Phase 3 Lymphoma, Follicular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 3 |
| Spectrum Pharmaceuticals, Inc | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Pfizer | 2 |
| Baxalta now part of Shire | 1 |
| CTI BioPharma | 1 |
| Favrille | 1 |
| Hutchison Medipharma Limited | 1 |
| MEI Pharma, Inc. | 1 |
| Martin, Paul | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Lymphoma, B-Cell, Marginal Zone | 7 |
| Lymphoma | 6 |
| Lymphoma, Non-Hodgkin | 5 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Burkitt Lymphoma | 3 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
| Leukemia, Myeloid, Chronic-Phase | 3 |
| Lymphoma, Large-Cell, Immunoblastic | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.